Literature DB >> 19482360

In-patient care costs of patients with bipolar I disorder: a comparison between two European centers.

A M Gonzalez-Pinto1, R Dardennes, M de Zélicourt, P López, R G Oliveros, E Vieta, S Barbeito, E Echevarria, F Fagnani.   

Abstract

BACKGROUND: Bipolar disorder (BPD) is a disabling disease with high morbidity rates. An international (Spain, France) comparative study about hospitalizations and in-patient care costs associated with BPD I was performed. Centers were included if they had access to a database of computerized patient charts exhaustively covering a defined catchment area.
METHODS: Economic evaluation was performed by multiplying the average cumulated annual length of stay (LOS) of hospitalized bipolar patients by a full cost per day of hospitalization in each center to obtain the corresponding annual costs.
RESULTS: Hospitalization rates per annum and per 100,000 individuals (general population aged 15+) were similar between France (43.6) and Spain (43.1). There were only slight differences in relation to length of stay (LOS) per patient hospitalized with 18.1 days in Spain and 20.4 days in France. The overall estimated annual hospitalization costs were in the same order of magnitude after adjustment to an adult population of 100,000: euro 232,000 (Spain) and euro 226,500 (France). Mixed episodes had the longest LOS followed by depressive episodes, while manic episodes had the shortest ones. Mania was the most costly disorder representing 53.7% of annual BPD in-patient care costs.
CONCLUSIONS: BPD I care requires large resources and frequent hospitalizations, especially during manic episodes. Depressive and mixed episodes require longer hospital stays than manic episodes. Out-patient costs should now be evaluated. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19482360     DOI: 10.1016/j.jad.2009.05.010

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  11 in total

1.  Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.

Authors:  Tatia Chay Woodward; Eskinder Tafesse; Peter Quon; Arthur Lazarus
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  Cost-of-illness studies for bipolar disorder: systematic review of international studies.

Authors:  Huajie Jin; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

3.  Bipolar Disorder Related Hospitalizations - a Descriptive Nationwide Study Using a Big Data Approach.

Authors:  Manuel Gonçalves-Pinho; Alberto Freitas; Orlando von Doellinger; João Pedro Ribeiro
Journal:  Psychiatr Q       Date:  2021-09-28

4.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

5.  Childhood maltreatment and the course of bipolar disorders among adults: epidemiologic evidence of dose-response effects.

Authors:  Regina Sala; Benjamin I Goldstein; Shuai Wang; Carlos Blanco
Journal:  J Affect Disord       Date:  2014-04-23       Impact factor: 4.839

6.  Number of prior episodes and the presence of depressive symptoms are associated with longer length of stay for patients with acute manic episodes.

Authors:  Manuel Martin-Carrasco; Ana Gonzalez-Pinto; Jaime L Galan; Javier Ballesteros; Jorge Maurino; Eduard Vieta
Journal:  Ann Gen Psychiatry       Date:  2012-03-10       Impact factor: 3.455

Review 7.  Cost of disorders of the brain in Spain.

Authors:  Oleguer Parés-Badell; Gabriela Barbaglia; Petra Jerinic; Anders Gustavsson; Luis Salvador-Carulla; Jordi Alonso
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

8.  Hospitalization Outcomes and Comorbidities of Bulimia Nervosa: A Nationwide Inpatient Study.

Authors:  Rikinkumar S Patel; Baris Olten; Priya Patel; Kaushal Shah; Zeeshan Mansuri
Journal:  Cureus       Date:  2018-05-05

9.  Hospital stay in patients admitted for acute bipolar manic episodes prescribed quetiapine immediate or extended release: a retrospective non-interventional cohort study (HOME).

Authors:  Oğuz Karamustafalıoğlu; Andreas Reif; Murad Atmaca; Domingo Gonzalez; Miriam Moreno-Manzanaro; Miguel Angel Gonzalez; Esteban Medina; Antonello Bellomo
Journal:  BMC Psychiatry       Date:  2014-08-31       Impact factor: 3.630

10.  Cognitive performance and psychosocial functioning in patients with bipolar disorder, unaffected siblings, and healthy controls.

Authors:  Mirela P Vasconcelos-Moreno; Joana Bücker; Kelen P Bürke; Leticia Czepielewski; Barbara T Santos; Adam Fijtman; Ives C Passos; Mauricio Kunz; Caterina Del Mar Bonnín; Eduard Vieta; Flavio Kapczinski; Adriane R Rosa; Marcia Kauer-Sant'Anna
Journal:  Braz J Psychiatry       Date:  2016-04-19       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.